First Zantac Cancer Risk Trial in California Postponed by Months First Zantac Cancer Risk Trial in California Postponed by Months

The first scheduled trial over claims that GSK ' s heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed, likely by several months.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news